Black Diamond Therapeutics, Inc.Black Diamond Therapeutics, Inc.Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

No trades
See on Supercharts

Price target

14.500.000.00%
The 6 analysts offering 1 year price forecasts for BDTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to BDTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BDTX EPS for the last quarter is −0.28 USD despite the estimation of −0.37 USD. In the next quarter EPS is expected to reach −0.31 USD. Track more of Black Diamond Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Black Diamond Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Black Diamond Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, BDTX price target is 14.50 USD with a max estimate of 20.00 USD and a min estimate of 9.00 USD. Check if this forecast comes true in a year, meanwhile watch Black Diamond Therapeutics, Inc. stock price chart and keep track of the current situation with BDTX news and stock market news.
We've gathered opinions of 7 analysts rating BDTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.